CD3 receptor (CD3)

CD3 receptor Overview

The CD3 receptor (Cluster of Differentiation 3) is a multi-protein complex expressed on the surface of T cells, essential for adaptive immune recognition and response. Functionally, the CD3 complex couples with the T cell receptor (TCR), which directly binds antigenic peptides presented via the Major Histocompatibility Complex (MHC). The CD3 complex consists of four primary subunits (γ, δ, ε, ζ), none of which bind antigen directly but are critical for transducing signals into the T cell following antigen engagement. Each CD3 subunit contains ITAM domains within their cytoplasmic tails; these motifs become phosphorylated by Src family kinases (notably LCK) after TCR-CD3 engagement, initiating signaling cascades that activate, proliferate, or differentiate the T cell[3][5][6][7][9]. CD3 is invariant among T cells, universally marking them and serving as a major diagnostic and therapeutic target. Drug targeting of CD3 can result in T cell activation, depletion, or immune redirection—providing utility in cancer, transplant, and autoimmune therapy, but carrying risks including immunosuppression, cytokine release syndrome, and other safety liabilities[3][5].

Mechanism of Action

Depletion of T cells via antibody-induced cytotoxicity (e.g., OKT3) Immune suppression via signaling modulation Redirected T cell activation against tumors/infected cells (bispecifics) Down-regulation/desensitization of T cell activation (via partial agonism or antagonism)

Biological Functions

Safety Considerations

Interacting Drugs

Associated Biomarkers